Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA

Virology

Volumn 261, Issue 2, 1999, Pages 227-241

  Atreya, Prabha L ^a   Kulkarni, Sandhya ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; INTERFERON; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEP 2 CELL; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VERO CELL; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SIMIAE; SYNCYTIAL VIRUS;

EID: 0344500647     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9835     Document Type: Article

References (49)

1. Anderson K., Fennie E. Adenovirus early region 1A modulation of interferon antiviral activity. J. Virol. 61:1987;787-795.
2. Anderson S. L., Carton J. M., Lou J., Xing L., Rubin B. Y. Interferon-induced guanylate-binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology. 256:1999;8-14.
3. Atreya P. L., Peeples M. E., Collins P. L. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J. Virol. 72:1998;1452-1461.
4. Belkowski L. S., Sen G. C. Inhibition of Vesicular Stomatitis Viral mRNA synthesis by interferons. J. Virol. 61:1987;653-660.
5. Bell D. M., Roberts N. J. Jr., Hall C. B. Different antiviral spectra of human macrophage interferon activities. Nature. 305:1983;319-321.
6. Bukreyev A., Whitehead S. S., Murphy B. R., Collins P. L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mice. J. Virol. 71:1997;8973-8982.
7. Collins P., McIntosh K., Chanock R. M. Respiratory syncytial virus. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;1313-1351 Raven Press, New York.
8. Collins P. L., Hill M. G., Cristina J., Grosfeld H. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. USA. 93:1996a;81-85.
9. Edmondson J. M., Armstrong L. S., Martinez A. O. A rapid and simple MTT-based spectrophotometric assay for determining the drug sensitivity in monolayer cultures. J. Tissue Cult. Methods. 11:1988;15-17.
10. Frese M., Kochs G., Feldmann H., Hertkorn C., Haller O. Inhibition of bunyaviruses, phleboviruses and hantaviruses by human MxA protein. J. Virol. 72:1996;915-923.
11. Garcia-Barreno B., Delgado T., Melero J. A. Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: Significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J. Virol. 70:1996;810-808.
12. Garcia-Barreno B., Palomo C., Penas C., Delgado T., Perez-Brenna P., Melero J. A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 63:1989;925-932.
13. Gardner P. S., McGuckin R., Beale A. J., Fernandes R. Interferon and respiratory syncytial virus. Lancet. 14:1970;574-575.
14. Hall C. B., Douglas G. R., Simmons R. L. Interferon production in adults with respirator syncytial virus infection. Ann. Intern. Med. 94:1981;53-55.
15. Hall C. B., Douglas G. R., Simmons R. L., Geiman J. M. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J. Pediatr. 93:1978;28-32.
16. Haller O., Frese M., Kochs G., Arzet H., Hefti H., Pavlovic J. Human MxA protein protects transgenic mice from infection with Thogoto virus (Abstract). J. Interferon Res. 13:1993;S121.
17. Haller O., Frese M., Rost D., Nuttall P. A., Kochs G. Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:1995;2596-2601.
18. Higgins P. G., Barrow G. I., Tyrrell D. A. J., Issacs D., Gauci C. L. The efficacy of intranasal interferon α-2a in respiratory syncytial virus infection in volunteers. Antiviral Res. 14:1990;3-10.
19. Hill D. A., Baron S., Chanock R. M. Sensitivity of common respiratory syncytial viruses to an interferon inducer in human cells. Lancet. 16:1969;187-188.
20. Horisberger M. A. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66:1992;4705-4709.
21. Horisberger M. A., McMaster G. K., Zeller H., Wathelet M. G., Dellis J., Content J. Cloning and sequence analyses of cDNAs for interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: Functional study of the corresponding gene promoter. J. Virol. 64:1990;1171-1181.
22. Kanerva M., Melen K., Vaheri A., Julkunen I. Inhibition of Puumala and Tula huntaviruses in Vero cells by MxA protein. Virology. 224:1996;55-62.
23. Karron R. A., Buonagurio D. A., Georgiu A. F., Whitehead S. S., Adamus J. E., Clements-Mann M. L., Harris D. O., Randolph V. B., Udem S. A., Murphy B. R., Sidhu M. S. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA. 94:1997;13961-13966.
24. Krajcsi P., Wold W. S. M. Viral proteins that regulate cellular signaling. J. Gen. Virol. 79:1998;1323-1335.
25. Krilov L. R., Hendry R. M., Godfrey E., McIntosh K. Respiratory virus infection of peripheral blood monocytes: Correlation with aging of cells and interferon production in vitro. J. Gen. Virol. 68:1987;1748-1753.
26. Landis H., Simon-Jodicke A., Kloti A., Di Paola C., Schnorr J.-J., Schneider-Schaulies S., Hefti H. P., Pavlovic J. Human MxA protein confers resistance to Semliki forest virus and inhibits the amplification of a Semliki forest-based replicon in the absence of viral structural proteins. J. Virol. 72:1998;1516-1522.
27. Leonard G. T., Sen G. C. Restoration of interferon responses of adenovirus E1A-expressing HT 1080 cell lines by overexpression of p48 protein. J. Virol. 71:1997;5095-5101.
28. McIntosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. J. Pediatr. 93:1978;33-36.
29. McKay E., Higgins P., Tyrrell D., Pringle C. Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers. J. Med. Virol. 25:1988;411-421.
30. Meier E., Kunz G., Haller O., Arnheiter H. Activity of rat Mx proteins against a rhabdovirus. J. Virol. 64:1990;6263-6269.
31. Melen K., Keskinen P., Ronni T., Sareneva T., Lounatmaas K., Julkanen I. Human MxB protein, an interferon-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem. 271:1996;23478-23486.
32. MMWR update: Respiratory syncytial virus activity-United States, 1997-1998 Season. MMWR46, 1163-1165.
33. Merolla R., Rebert N. A., Tsiviste P. T., Hoffmann S. P., Panuska J. R. Respiratory syncytial virus replication in human lung epithelial cells: Inhibition by tumor necrosis factor α and interferon β Am. J. Respir. Crit. Care Med. 152:1995;1358-1366.
34. Moehring J. M., Forsyth B. R. The role of interferon system in respiratory syncytial virus infections. Proc. Soc. Exp. Biol. Med. 138:1971;1009-1014.
35. Pavlovic J., Zurcher T., Haller O. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:1990;3370-3375.
36. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their action. Annu. Rev. Biochem. 56:1987;727-777.
37. Pitossi F., Blank A., Schroder A., Schwarz P., Hussi M., Schwemmle J., Pavlovic J., Staheli P. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J. Virol. 67:1993;6726-6732.
38. Roberts N. J. Jr., Hiscott J., Signs D. J. The limited role of the human interferon system response to respiratory syncytial virus challenge: Analysis and comparison to influenza virus challenge. Microb. Pathol. 12:1992;409-414.
39. Samuel C. E. Minireview: Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
40. Schneider-Schaulies S., Schneider-Schaulies J., Schuster A., Bayer M., Pavlovic J., ter Meulin V. Cell type-specific MxA-mediated inhibition of Measles virus transcription in human brain cells. J. Virol. 68:1994;6910-6917.
41. Schnorr J.-J., Schneider-Schaulies S., Simon-Jodicke A., Pavlovic J., Horisberger M. A., ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:1993;4760-4768.
42. Smith G. L. Virus proteins that bind cytokines, chemokines or interferons. Curr. Opin. Immunol. 8:1996;467-471.
43. Staeheli P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200.
44. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers resistance to influenza virus. Cell. 44:1986;157-158.
45. Staeheli P., Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 65:1991;4498-4501.
46. Sung R. Y. T., Yin J. S., Oppenheimer J., Tam J. S., Lau J. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch. Dis. Child. 69:1993;440-442.
47. Teng M., Collins P. L. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J. Virol. 73:1999;466-473.
48. Zerial A., Hovanessian A. G., Stefanos S., Huygen K., Werner G. H., Falcoff E. Synergistic activities of type I (α and β) and type II (γ) murine interferons. Antiviral Res. 2:1982;227-139.
49. Zhao H., De B. P., Das T., Banerjee A. K. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology. 220:1996;330-338.